Erratum to: population pharmacokinetics and exposure-uric acid analyses after single and multiple doses of ABT-639, a calcium channel blocker, in healthy volunteers
AAPS J. 2015 Mar;17(2):481-92.
doi: 10.1208/s12248-015-9725-9.
1 Department of Clinical Pharmacology and Pharmacometrics, Research and Development, AbbVie, 1 North Waukegan Road North, Chicago, Illinois, 60064, USA, [email protected].